Acute Respiratory Insufficiency Clinical Trial
— WEANINGOfficial title:
Comparison of Two Ventilatory Modes During Spontaneous Breathing Trial in Intubated Patients
Verified date | November 2018 |
Source | Hospices Civils de Lyon |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Patients who are intubated and mechanically ventilated for acute respiratory failure in the
Intensive Care Unit (ICU) are at some point eligible for weaning. The common way to wean them
from mechanical ventilation is to screen criteria for feasibility and, if present, to test
feasibility by performing spontaneous breathing trial. This latter can be done either by
setting a low pressure support level (expected to compensate the airflow resistance due to
endotracheal tube) or by allowing the patient to breathe spontaneously through the tube
without any support from the ventilator. Combination of low pressure assistance strategy (7
cm H2O) and positive expiratory pressure (PEP) of 4 cm H2O is the strategy used in our unit.
Such a low pressure support level should actually result in a real assistance and, hence this
is not the real spontaneous breathing capacity that is tested. Some ICU ventilators offer the
option of compensating for the airflow resistance due to endotracheal tube, automatic tube
compensation (ATC). Therefore, investigators aimed at comparing in patients ready to wean the
usual procedure in our ICU and the ATC mode. In the ATC arm, the patients are breathing
spontaneously through the endotracheal tube and are connected to the ventilator set at
inspiratory pressure support of 0 cm H2O, PEP 4 cm H2O and ATC on.
Two parallel arms depending on the order of allocation of each mode: pressure support 7 cm
H2O + PEP 4 cm H2O then ATC or the opposite. The primary endpoint is the power of the work of
breathing. The hypothesis is that the power of the work of breathing is greater in ATC than
in the usual procedure, and hence this latter is a real ventilator support.
Status | Completed |
Enrollment | 20 |
Est. completion date | October 5, 2018 |
Est. primary completion date | October 5, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - age 18 years or more - intubated and mechanically ventilated for at least 24 consecutive hours - staying in the medical ICU at the Croix Rousse Hospital, Lyon, France - pressure support ventilation 10-15 cm H2O, total respiratory rate 25-35 breaths/min, expired tidal volume 6-8 ml/kg predicted body weight - meeting criteria for spontaneous breathing trial (able to answer simple questions, no ongoing intravenous sedation, norepinephrine = 1 mg/H, dobutamine = 20 mg/h, fraction of inspired oxygen (FIO2 = 50%), PEP = 5 cm H2O, respiratory rate = 35 breaths/min, saturation in oxygen (SpO2) =88%) - under Dräger Evita XL ou V500 ICU ventilator - agreement to participate from the patient or next of kin Exclusion Criteria: - Chronic respiratory failure under long term home oxygen therapy and/or non invasive ventilation before ICU admission - Tracheotomy - nasogastric tube contra-indicated - thoracic tube in place - no agreement to participate - under justice protection - deprived of freedom - pregnant or breastfeeding - not affiliated to social insurance - involved into another study that may interfere with present study |
Country | Name | City | State |
---|---|---|---|
France | Hôpital de la Croix Rousse | Lyon |
Lead Sponsor | Collaborator |
---|---|
Hospices Civils de Lyon |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | the power of work of breathing | the work of breathing is measured from the area subtended by the esophageal pressure - lung volume relationship. The power of work of breathing is obtained by multiplying work of breathing by the respiratory frequency and expressed in Joules/min | 30 minutes after onset the ventilator strategy | |
Secondary | Respiratory rate | the respiratory rate is measured from the airflow tracing | 30 minutes | |
Secondary | tidal volume | integration of airflow over time during expiration | 30 minutes | |
Secondary | intrinsic PEP | deflection in esophageal pressure up to the first zero flow | 30 minutes | |
Secondary | occlusion pressure at 100 ms | measured from the airway pressure at the first 100 ms after airway occlusion | 30 minutes | |
Secondary | work of breathing per liter | work of breathing normalized for 1 liter tidal volume | 30 minutes | |
Secondary | Distribution of pulmonary ventilation | distribution of pulmonary ventilation will be measured by the Pulmovista system | 30 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02592512 -
NIV-NAVA vs NIV-PS/PC in Respiratory Insufficiency
|
N/A | |
Completed |
NCT00835809 -
Multi Marker Approach Interest in Emergency in Acute Respiratory Insufficiency Diagnostic
|
N/A | |
Recruiting |
NCT04791501 -
Prevalence AND Outcome of Acute Hypoxemic Respiratory fAilure in CHILDren (PANDORA-CHILD)
|
||
Completed |
NCT03358043 -
Prevalence and Outcome of Acute Hypoxemic Respiratory Failure in Wales
|
||
Completed |
NCT01931228 -
Mechanical Insufflation-Exsufflation in Preventing Post Extubation Respiratory Failure in Patient With Critical Care Neuromyopathy
|
N/A | |
Completed |
NCT03145974 -
Prevalence and Outcome of Acute Hypoxemic Respiratory Failure
|
||
Completed |
NCT01901497 -
Pharmacokinetics of Nebulized Amikacin in Non Invasive Ventilated Healthy Volunteers.
|
N/A | |
Completed |
NCT00686257 -
Evaluation Of The Total Face Mask For Emergency Application In Acute Respiratory Failure
|
N/A | |
Completed |
NCT04346693 -
An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug in Patients With Severe and Critical Manifestations of SARS-COVID-19
|
Phase 3 |